Oxfam welcomes Gilead’s historic decision to make HIV drugs accessible to poor 12 July 2011 Oxfam today praised the Medicine Patent Pool (MPP) for securing the first licenses for HIV medicines with the pharmaceutical company Gilead, a move that will boost the affordability and eff
Eye on the Ball 2 February 2011 Poor-quality, or “substandard”, medicines threaten patients and public health in developing countries.
Better Returns in a Better World 18 November 2010 This paper summarizes a two-year research engagement project with the investment community on their rol
